You Are Here: Home » Economic Development » Malloy proposes $200M bioscience investment

Malloy proposes $200M bioscience investment

Malloy proposed yesterday an additional investment of $200 million into the state’s bioscience initiative to continue the industry’s growth in the region. It will be a part of Malloy’s budget proposal in February.

The investment, made over 10 years, would be administered by the state’s quasi-public economic development entity, Connecticut Innovations (CI).

Through CI, the funding would primarily be used to attract and invest in bioscience companies, with the goal of creating a thriving industry in Connecticut with well-paying jobs.

“Ongoing investment in bioscience will result in high-value job growth,” said Claire Leonardi, CI executive director, in a press release. “This plan ensures we continue to build a strong base in the short term, and in the long term it allows us to leverage additional investment to increase overall economic growth.”

An investment made previously to Jackson Laboratory for Genomic Medicine, the poster child of the bioscience initiative, is expected bring 6,800 permanent jobs to Connecticut by the end of 20 years.

Print

About The Author

Jennifer Bissell
Reporter

Jennifer Bissell is a reporter for both the Fairfield and Westchester business journals. Previously she attended the University of Minnesota and contributed to several regional publications including the St. Paul Pioneer Press, St. Cloud Times and Twin Cities Business magazine.

Number of Entries : 877

Leave a Comment


Copyright Westfair Business Publications • All rights reserved • Reproduction in whole , or in part, without written permission is strictly prohibited
Westfair Communications Inc. • 3 Gannett Drive, Suite G7 • White Plains, NY 10604-3407 • Tel: (914) 694-3600
Scroll to top